Pregnant women are at increased risk for influenza-related morbidity, adverse pregnancy outcomes, and mortality, especially during pandemics.1 – 9 During the 2009 H1N1 pandemic, pregnant women accounted for approximately 5% of influenza-associated deaths in the United States, although they represent only approximately 1% of the population.6
Influenza vaccination during pregnancy is the most effective way to prevent influenza virus infection among pregnant women10 and their infants younger than 6 months of age.11,12 Although administration of inactivated influenza vaccine is recommended to all women who are pregnant during the influenza season, regardless of pregnancy trimester,10,13 the vaccination coverage among pregnant women has been historically low, rarely exceeding 15% during nonpandemic years.10,14 The reasons for low uptake of vaccination during pregnancy include factors related to the lack of vaccine acceptance by pregnant women, as well as barriers among health care providers, including absence of financial incentives, liability concerns, logistic obstacles, and lack of confidence about vaccine safety and benefits.15 – 22
Obstetrician–gynecologists (ob-gyns), who are often the only providers of health care during pregnancy, play a critical role in preventing influenza in their patients through vaccination and implementing recommended diagnostic, treatment, and infection control practices. Understanding the barriers that prevent ob-gyns from administering influenza vaccination is critical for attaining high vaccination rates among pregnant women. In February 2010, just after the peak of the 2009 H1N1 pandemic, we conducted a survey among the national sample of U.S. ob-gyns to assess their knowledge, attitudes, and practices regarding influenza vaccination during pregnancy, and the barriers and facilitators to influenza vaccination.
MATERIALS AND METHODS
A self-administered survey was mailed to a U.S. nationally representative random sample of 3,116 ob-gyns using the American College of Obstetricians and Gynecologists database. Only ob-gyns currently involved in obstetric patient care were eligible to participate; those not eligible were instructed to return the uncompleted survey. The sampling frame consisted of 33,685 practicing ob-gyns who were College fellows or junior fellows. The survey was accompanied by a cover letter and prepaid envelope; no incentives were offered to the participants. The initial mailing was sent in February 2010. Second, third, and fourth mailings were sent to all nonrespondents at 4- to 5-week intervals. The survey included questions about the basic demographic information of respondents and their patients, respondents' experiences with serious conditions attributed to influenza-like illness among pregnant women in their practice (during both 2008–2009 influenza season and 2009 H1N1 pandemic), and respondents' attitudes and practices regarding influenza vaccination of pregnant women (with both seasonal and 2009 H1N1 influenza vaccines) during the 2009 H1N1 pandemic. Five weeks after the fourth mailing, a short questionnaire was sent to all nonrespondents to gather data for an assessment of possible nonresponse bias in which their responses were compared with those of study participants.
Analyses were performed using SAS 9.1 and SPSS 16.0. We calculated frequency distributions of responses to each question in the survey, excluding nonresponses from the denominators. For multilevel responses, we performed multiple tests using SAS “MULTTEST” procedure. Two-sided Cochran-Armitage linear trend tests23 and a significance level of P<.05 were used to compare differences in responses for the 2008–2009 and 2009–2010 influenza seasons, and for seasonal and 2009 H1N1 influenza vaccines.
To assess the association between selected characteristics and routinely offering 2009 H1N1 influenza vaccine by ob-gyns, we conducted log-binomial regression analyses, which included variables on the basis of their univariable association with the outcome (routinely offering 2009 H1N1 influenza vaccine); adjusted prevalence ratios and 95% confidence intervals (CIs) were calculated using SAS “GENMOD” log-binomial regression capability.24 Using this approach, log-probability link function is used, and the adjusted estimates of coefficients of the examined factors represent logarithms of the adjusted prevalence ratios. Because of multicollinearity between three variables (practice type, considers primary care or preventive medicine an important part of practice, and received 2009 H1N1 influenza vaccination themselves), three separate models were constructed. The project was reviewed for human subject concerns by the Centers for Disease Control and Prevention and the College and was determined to qualify for exempt status.
Of the 3,116 surveys mailed, 20 were returned as undeliverable. Among the ob-gyns who received the survey, 1,784 did not respond, 2 refused participation, and 1,310 returned the survey for a response rate of 42.3% (1,310 of 3,096). Of 1,310 providers who returned the surveys, 873 (66.6%) were providing obstetric care during the 2009–2010 influenza season and therefore were eligible to participate in the study, and their responses were included in the analyses.
The respondents had a mean age of 49 years, approximately half were female, and their average duration of clinical practice was 17 years (Table 1). The majority of respondents were practicing in a group obstetrics-gynecology practice (48.1%), followed by solo practice (16.4%), multispecialty group practice (12.4%), university full-time faculty and practice (11.2%), and other (11.9%, including Health Maintenance Organization, military, and combination of these). Almost all respondents considered primary care or preventive medicine an important part of their clinical practice. Among the patient population of the respondents, a third were eligible for Medicaid, and race or ethnicity distribution was as follows: 54.9% were non-Hispanic white, 15.2% were non-Hispanic African American, 17.8% were Hispanic, 5.3% were Asian or Pacific Islander, and 1.3% were Native American.
In response to the question “During last year's (2008–2009) and this year's (2009–2010) influenza seasons, have you seen the following conditions in your practice that you attribute to influenza-like illness,” the proportion of ob-gyns who reported observing at least one of the serious conditions (maternal death, pneumonia requiring intensive care, spontaneous abortion or stillbirth, or preterm birth) doubled from 14.6% during the 2008–2009 influenza season to 31.1% during the 2009–2010 influenza season (P<.001). During the 2009 H1N1 pandemic, survey results indicated a threefold increase in the proportion of ob-gyns who reported observing maternal deaths, twofold increase in the proportion observing pneumonias requiring intensive care, twofold increase in the proportion observing spontaneous abortions or stillbirths, and 50% increase in the proportion observing preterm births attributed to influenza-like illness (based on their clinical judgment) compared with the previous influenza season (Fig. 1).
During the 2009 H1N1 pandemic (2009–2010 influenza season), the majority of ob-gyns reported routinely offering influenza vaccination, both seasonal (77.6%) and 2009 H1N1 (85.6%), to their pregnant patients; most of the remaining providers reported referring their patients to other providers for seasonal (21.1%) and 2009 H1N1 (13.3%) vaccines. Only approximately 1% of providers neither offered nor referred their pregnant patients for influenza vaccination (Table 2). Pregnant patients with underlying chronic conditions were offered vaccine at approximately the same rate as low-risk patients; however, providers were slightly less likely to offer both seasonal and 2009 H1N1 influenza vaccines for pregnant patients with prepregnancy obesity. The following reasons for not offering vaccinations were reported by ob-gyns (percentages for seasonal and 2009 H1N1 influenza vaccines, respectively): not adequately reimbursed by insurance (34.9% and 31.7%); no adequate storage and handling facilities for vaccines (28.0% and 35.8%); vaccine offered by closely affiliated clinic (21.7% and 28.5%); managed care contract does not cover the cost of vaccines and vaccine administration (20.1% and 17.1%); and belief that vaccines should be administered by another provider, such as an internist or family practitioner (15.3% and 14.6%). Although the percentage of respondents offering influenza vaccination to pregnant women was significantly greater for the 2009 H1N1 influenza vaccine as compared with seasonal influenza vaccine, recommendations to use influenza vaccine did not differ by vaccine type (seasonal or 2009 H1N1). The majority of respondents recommended influenza vaccination at any trimester of pregnancy; however, 10–11% recommended influenza vaccination only during the second or third trimester of pregnancy (Table 2). Almost all respondents reported that their medical practice either required (approximately 34%) or strongly encouraged (62–63%) them to receive an influenza vaccination, and almost all (90–92%) reported having actually received an influenza vaccination during the previous influenza season. Unvaccinated respondents provided the following reasons for not getting vaccination: unable to find the vaccine; had allergic reaction to influenza vaccines in the past; had influenza before vaccine became available; had no time for vaccination; or stated that there was no particular reason. These reasons did not differ by vaccine type.
The most commonly cited sources of guidance regarding influenza vaccinations were the College and the Centers for Disease Control and Prevention, cited by 60.8% and 54.1% respondents, respectively. Other sources of information included local public health departments (18.8%), their own practice (11.9%), scientific literature (5.6%), and media (3.9%). Fewer than half (46.6%) of respondents stated that they report suspected adverse events after administering influenza vaccine; when asked how adverse events should be reported, only 13.1% specified the Vaccine Adverse Event Reporting System or Centers for Disease Control and Prevention (which cosponsors Vaccine Adverse Event Reporting System).
Among ob-gyns, predictors of routinely offering the 2009 H1N1 vaccination to pregnant women included considering primary care or preventive medicine to be a very important part of practice (adjusted prevalence ratio 1.2, CI 1.01–1.4), observing serious conditions attributed to influenza-like illness in their practice (adjusted prevalence ratio 1.1, CI 1.02–1.1), and personally receiving 2009 H1N1 influenza vaccination (adjusted prevalence ratio 1.2, CI 1.1–1.4; Table 3). In addition, practice type was an independent predictor of routinely offering 2009 H1N1 vaccine; compared with providers in group obstetrics-gynecology practice, providers in solo practice were less likely (adjusted prevalence ratio 0.8, CI 0.7–0.9) and providers in multispecialty group were more likely (adjusted prevalence ratio 1.1, CI 1.1–1.2) to offer 2009 H1N1 influenza vaccine. The 202 nonrespondents who returned the short follow-up letter survey did not differ from the full survey respondents in years of clinical practice, proportion of patients eligible for Medicaid, or the likelihood of routinely offering influenza vaccinations to pregnant women.
During the 2009 H1N1 pandemic, ob-gyns were critical to the public health response for preventing severe complications of influenza virus among pregnant women. Although most ob-gyns participating in this survey routinely offered influenza vaccinations to their patients, a considerable proportion of respondents did not offer vaccination or did not recommend vaccination in the first trimester of pregnancy, which represents a missed opportunity for preventing influenza virus infection and its serious consequences.
We found that ob-gyns routinely offered seasonal and 2009 H1N1 influenza vaccines to their pregnant patients during the 2009–2010 influenza season at a higher rate than reported from surveys of U.S. ob-gyns in previous influenza seasons,15,18 – 22,25 which could be attributable to increased awareness regarding influenza in pregnancy during the pandemic season and increased demand for vaccination among pregnant women. Our study showed that providers who observed at least one of the serious conditions attributed to influenza-like illness were more likely to offer 2009 H1N1 influenza vaccine to their pregnant patients. In addition, during the 2009 H1N1 pandemic, ob-gyns were frequently reminded about the importance of influenza vaccination during pregnancy by media, publications in scientific journals, and letters from professional associations and governmental agencies.26 Provision of 2009 H1N1 vaccine at no cost to vaccination providers could also have motivated ob-gyns to become vaccinators and may explain why more providers offered 2009 H1N1 than seasonal influenza vaccine. Recently published influenza vaccination coverage rates among pregnant women support our finding of the significant increase in providing vaccination among ob-gyns; in the 2009–2010 influenza season, approximately 50% of pregnant women received influenza vaccination,27 which is the highest coverage level ever reported in the United States, getting closer to the Healthy People 2020 goal of 80% coverage.28
Barriers to recommending and administering influenza vaccination among ob-gyns in our sample included inadequate reimbursement and absence of storage and handling facilities for vaccines (which require refrigeration and protection from light). These financial and logistic concerns are not unique for influenza vaccines and have been consistently reported in previous surveys of obstetric providers.15 – 19,21,22 However, concerns about the safety of influenza vaccines reported in previous studies19,22 were uncommon in our survey, which occurred toward the end of the 2009–2010 influenza season, when speculations about safety of influenza vaccination had been mitigated. Solo practice providers, which represented 16.4% of ob-gyns in our sample, were less likely to offer influenza vaccination, but more likely (compared with other practice types) to consider primary care or preventive medicine a very important part of their clinical practice (analysis not shown). This suggests that barriers to vaccination among solo practice providers are more difficult to overcome than among those who practice in partnerships and groups.
One of the limitations of the study is the relatively low response rate, which is, however, slightly higher than reported in previous random surveys of general College members (averaged 40%).29 It is also possible that characteristics of respondents are different from that of nonrespondents, although nonresponse bias analysis did not reveal statistically significant differences for comparison variables. Importantly, the characteristics of respondents in our sample are similar to those of U.S. ob-gyns in general,30 and the characteristics of their patients are similar to those of U.S. women giving birth.31 As with most surveys, our study has inherent limitations of self-reported data, which can be subject to response bias. Because we collected our data immediately after the 2009 H1N1 pandemic season, our findings may not be generalizable to a nonpandemic influenza season, when fewer patients experience serious consequences of influenza, demand for vaccination is decreased, vaccine is no longer free, and pressure from professional associations is lower. Preliminary data from the 2010–2011 influenza season suggest that observed improvement of influenza vaccination coverage rates among pregnant women could be sustainable.32
Improving vaccination coverage rates during pregnancy is one of the main public health goals during both influenza pandemics and nonpandemic influenza seasons, because of its role in decreasing influenza-related morbidity and mortality among pregnant women and their young infants. For many women, ob-gyns are the only providers of health care.33 By not offering influenza vaccination to such women, providers miss a unique opportunity for prevention. Although demand for influenza vaccination from pregnant women plays an important role, research shows that when women are offered vaccination, most tend to accept it.15,20,27,34,35 Given that influenza vaccination reduces health care, societal, and individual costs, as well as productivity losses and absenteeism associated with influenza,10 policy improvements to allow more reliable reimbursement for vaccine providers, especially those in solo practice, might be beneficial for the society. A number of strategies (eg, patient reminder systems) have been successful in improving the role of obstetric providers as vaccinators and need to be used more widely,36 – 38 which can become even more feasible when electronic health records are widely implemented. Ob-gyns played a crucial role in increasing the national influenza vaccination coverage rates among pregnant women during the 2009 H1N1 pandemic and need to sustain their role as vaccinators during coming influenza seasons.
1. 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care-New York City, 2009. MMWR Morb Mortal Wkly Rep Mar 2010;26;59:321–6.
2. Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al.. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007;176:463–8.
3. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al.. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451–8.
4. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362:27–35.
5. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998;148:1094–102.
6. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al.. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010;303:1517–25.
7. Harris J. Influenza occurring in pregnant women. JAMA 1919;72:978–80.
8. Nishiura H. Excess risk of stillbirth during the 1918–1920 influenza pandemic in Japan. Eur J Obstet Gynecol Reprod Biol 2009;147:115.
9. Nuzum JW, Pilot I, Stangl FH, Bonar BE. 1918 pandemic influenza and pneumonia in a large civil hospital. IMJ Ill Med J 1976;150:612–6.
10. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al.. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59(RR-8):1–62.
11. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al.. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359:1555–64.
12. Eick AA, Uyeki TM, Klimov A, Hall H, Reid R, Santosham M, et al.. Maternal Influenza Vaccination and Effect on Influenza Virus Infection in Young Infants. Arch Pediatr Adolesc Med 2011;165:104–11.
13. Influenza vaccination during pregnancy. ACOG Committee Opinion No. 468. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:1006–7.
14. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, U.S., 1989–2005. Vaccine 2008;26:1786–93.
15. Gonik B, Jones T, Contreras D, Fasano N, Roberts C. The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization. Obstet Gynecol 2000;96:81–4.
16. Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006;28:47–53.
17. Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. J Matern Fetal Neonatal Med 2011;24:402–6.
18. Power ML, Leddy MA, Anderson BL, Gall SA, Gonik B, Schulkin J. Obstetrician-gynecologists' practices and perceived knowledge regarding immunization. Am J Prev Med 2009;37:231–4.
19. Schrag SJ, Fiore AE, Gonik B, Malik T, Reef S, Singleton JA, et al.. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol 2003;101:704–10.
20. Silverman NS, Greif A. Influenza vaccination during pregnancy. Patients' and physicians' attitudes. J Reprod Med 2001;46:989–94.
21. Wallis DH, Chin JL, Sur DK. Influenza vaccination in pregnancy: current practices in a suburban community. J Am Board Fam Pract 2004;17:287–91.
22. Wu P, Griffin MR, Richardson A, Gabbe SG, Gambrell MA, Hartert TV. Influenza vaccination during pregnancy: opinions and practices of obstetricians in an urban community. South Med J 2006;99:823–8.
23. Agresti A. Categorical data analysis. 2nd ed. New York (NY): John Wiley & Sons; 2002.
24. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005;162:199–200.
25. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists–United States, 2003–04 influenza season. MMWR Morb Mortal Wkly Rep 2005;54:1050–2.
27. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women–10 states, 2009–10 influenza season. MMWR Morb Mortal Wkly Rep 2010;59:1541–5.
29. Stanwood NL, Garrett JM, Konrad TR. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 2002;99:275–80.
31. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Mathews Osterman MJK. Births: Final data for 2008. National vital statistics reports, volume 59, no 1. Hyattsville (MD): National Center for Health Statistics; 2010.
33. Willson JR, Burkons DM. Obstetrician-gynecologists are primary physicians to women. Am J Obstet Gynecol 1976;126:744–54.
34. Yeager DP, Toy EC, Baker B III. Influenza vaccination in pregnancy. Am J Perinatol 1999;16:283–6.
35. Yudin MH, Salripour M, Sgro MD. Impact of patient education on knowledge of influenza and vaccine recommendations among pregnant women. J Obstet Gynaecol Can 2010;32:232–7.
36. Jacobson VJ, Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003941. DOI: 10.1002/14651858.CD003941.pub2.
37. Ndiaye SM, Hopkins DP, Shefer AM, Hinman AR, Briss PA, Rodewald L, et al.. Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review. Am J Prev Med 2005;28(5 Suppl):248–79.
38. Walsh JM, McPhee SJ. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q 1992;19:157–75.